THC-COOH11-nor-9-carboxy-Δ9-tetrahydrocannabinol acid
Inactive THC metabolite, the main analyte of urine cannabis tests.
C₂₁H₂₈O₄
CAS 56354-06-4
- Family
- Metabolite
- Molar mass
- 344.44 g/mol
Updated on
In plain terms
THC-COOH does not exist in the plant: it is the form THC takes once the body has transformed it. It produces no psychotropic effect. It stays detectable in urine for a long time, and it is what cannabis drug tests look for.
Receptors and activity
Pharmacology
11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) is the oxidised metabolite of Δ9-THC: hydroxylation at C11, mainly by CYP2C9, gives the psychoactive 11-OH-THC, whose oxidation produces the inactive THC-COOH; this is then conjugated with glucuronic acid, and that glucuronide is the main urinary metabolite (Huestis 2007). Its elimination is slow: in the studies gathered by Huestis (2007), the mean plasma elimination half-life was 5.2 days in frequent users and 6.2 days in occasional users, and the terminal urinary half-life after oral intake about 2 to 3 days. In 70 adolescents and young adults followed during verified abstinence, Schuster et al. (2020) estimated a half-life of 2 days and a detection window of 10 days, with an estimated range of 4 to 80 days. Urine drug tests target this molecule, with a US federal cutoff of 50 ng/mL by immunoassay and 15 ng/mL for confirmation by chromatography coupled with mass spectrometry; creatinine normalisation is used to tell a new intake from residual elimination.
Key sources.
- Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4:1770-1804 (new tab)PMID 17712819
- Schuster RM et al. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence. J Psychopharmacol 2020 (new tab)PMID 31535597
- Fraser AD, Worth D. Urinary excretion profiles of 11-nor-9-carboxy-Δ9-THC and 11-hydroxy-Δ9-THC: cannabinoid metabolites to creatinine ratio study IV. Forensic Sci Int 2004;143:147-152 (new tab)PMID 15240035
- Zurier RB et al. Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis Rheum 1998;41:163-170 (new tab)PMID 9433882
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (annex III, « Tetrahydrocannabinols… »; annex IV, « benzo[c]chromene » clause) (new tab)
- PubChem, (6aR,10aR)-11-nor-9-carboxy-Δ9-THC, CID 108207 (new tab)
History
- Source
- No occurrence in the plant is documented. THC-COOH forms in the body by oxidation of Δ9-THC, after any form of exposure. It is the main urinary metabolite of THC, excreted mostly as a glucuronide linked to the acid group (Huestis 2007).
Metabolic pathway
No plant pathway. In the body, Δ9-THC is first hydroxylated at C11, mainly by CYP2C9, to 11-OH-THC, a psychoactive metabolite; oxidation of the latter gives THC-COOH, which is inactive. In phase II, THC-COOH is conjugated with glucuronic acid (Huestis 2007).
Legal framework
- European Union
No schedule of the United Nations conventions names THC-COOH: the 1971 Convention lists Δ9-THC (Schedule II) and six tetrahydrocannabinol isomers (Schedule I), not their metabolites. The European Union keeps no list of its own; the metabolite's status falls to each Member State's law. No marketing authorisation covers this molecule.
- France
THC-COOH is not named on any French list. The entry "Tetrahydrocannabinols, their esters, ethers, salts as well as the salts of the aforementioned derivatives" of the narcotics list (decree of 22 February 1990), moved to annex III by the ANSM decision of 6 February 2026, does not mention oxidised metabolites. The generic "benzo[c]chromene" clause of annex IV (decisions of 22 May and 3 June 2024) allows at position 9 only a ketone, alkyl, hydroxyalkyl or alkoxy group, not the carboxylic acid this metabolite carries. No published decision settles its case. Its presence in a biological sample is the trace of past cannabis exposure: it is the molecule that urine drug tests look for.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Metabolite
- Chemistry
C5 side chain
- Parent molecule
Inactive metabolite.
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
11-Nor-9-carboxy-THC (new tab)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4:1770-1804 (new tab)PMID 17712819
- Schuster RM et al. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence. J Psychopharmacol 2020 (new tab)PMID 31535597
- Fraser AD, Worth D. Urinary excretion profiles of 11-nor-9-carboxy-Δ9-THC and 11-hydroxy-Δ9-THC: cannabinoid metabolites to creatinine ratio study IV. Forensic Sci Int 2004;143:147-152 (new tab)PMID 15240035
- Zurier RB et al. Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis Rheum 1998;41:163-170 (new tab)PMID 9433882
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (annex III, « Tetrahydrocannabinols… »; annex IV, « benzo[c]chromene » clause) (new tab)
- PubChem, (6aR,10aR)-11-nor-9-carboxy-Δ9-THC, CID 108207 (new tab)
Identifiers
Names
- Common name
- 11-nor-9-carboxy-Δ9-tetrahydrocannabinol acid
- IUPAC name
- (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
- Other names
- THC-COOH · 11-COOH-THC · 11-nor-9-carboxy-Δ9-THC · carboxy-THC
Identifiers
- Formula
- C₂₁H₂₈O₄
- CAS
- 56354-06-4
- PubChem CID
- 108207(new tab)
- ChEBI
- CHEBI:77273(new tab)
- InChIKey
- YOVRGSHRZRJTLZ-HZPDHXFCSA-N
- SMILES
- CCCCCC1=
CC(= C2[C@@H] 3C= C(CC[C@H] 3C(OC2= C1) (C) C) C(= O) O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.